There are around 16 variants of GSD plus sub-variants, making about 25 in total. They are classified by a number and by the name of the defective enzyme, and sometimes by the name of the doctor who first described the condition.
(As an example: GSD1, a defect in the enzyme glucose-6-phosphatase, is also known as Von Gierke disease. It is subdivided into 1a and 1b.)
We provide information on the lead GSDs
You can follow the links in the display list to read about the lead GSDs. The UK patient numbers for these lead GSDs vary from under 10 to over 300. For each GSD the degree of support needed, the amount known about them, and the availability of treatments also varies considerably.
Grouping of GSDs
The various GSDs can be informally, and somewhat imperfectly, grouped by certain key aspects:
Hepatic (GSD1) – Orange –
Hepatic/Ketotic (GSDs 0, 3, 6 & 9) – Green –
Lysosomal (GSD2) – Yellow –
Muscle (GSDs 4, 5 & 7) – Blue –
Rather confusingly GSDs 0, 3, 4 and 9 have both liver and muscle aspects or sub-types, but we have grouped them by their main attributes.
Liver and muscle forms. UK diagnosed: under 20.
GSD1 - Von Gierke disease
Liver. UK diagnosed: about 300.
GSD2 - Pompe disease
Neuromuscular. UK diagnosed: about 200.
GSD3 - Cori disease
Liver, except two sub types also involve muscle. UK diagnosed: about 150.
GSD4 - Andersen disease
Liver and muscle forms. UK diagnosed: about 50.
GSD5 - McArdle disease
Skeletal muscle. UK diagnosed: about 350.
GSD6 - Hers disease
Liver. UK diagnosed: about 50.
GSD7 - Tarui disease
Skeletal muscle. UK diagnosed: under 20.
Liver and muscle forms. UK diagnosed: about 150.
- GSD8 has been reclassified as a sub-variant of GSD6.
- For GSD10 and above see the “Other GSDs” page.
- The “UK diagnosed” figures are our best estimates based on various incidence rates published by medical sources, an AGSD-UK audit of English NHS specialist centres, our own figures from members and other people registered with us, and our experience of the rate of diagnosis.
Are you affected by another GSD?
There are currently about 9 other ultra rare GSDs, and our mission is to support people affected by all GSDs, no matter how rare. So far only one or two of these GSDs have any diagnosed UK patients.
Maps of people with GSDs
For some GSDs we are in touch with almost all affected in the UK, but for other GSDs we are only in touch with a subset. The reasons are varied, from a low rate of diagnosis, to not being told of our existence snd not feeling the need for any information or support. Others make use of our information but do not register with us.
We are continually improving our outreach through clinicians and through raising awareness.
Our maps give a good impression of numbers and geographical spread of people with the various GSDs who have registered with us.